356784 <common-name>4,4-bis(3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)-1,2-diphenylpyrazolidine-3,5-dione</common-name> <description>4,4-bis(3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)-1,2-diphenylpyrazolidine-3,5-dione is a chemical compound with the formula C45H32N6O6. With an average molecular weight of 752.80 g/mol, 4,4-bis(3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)-1,2-diphenylpyrazolidine-3,5-dione is a heavy molecule.</description> <cas>3812-22-4</cas> <pubchem-id>77429</pubchem-id> <chemical-formula>C45H32N6O6</chemical-formula> <weight>752.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-09-01T03:29:20Z</created-at> <updated-at type="dateTime">2026-09-01T03:29:20Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)C4(C(=O)N(N(C4=O)C5=CC=CC=C5)C6=CC=CC=C6)C7C(=O)N(N(C7=O)C8=CC=CC=C8)C9=CC=CC=C9</moldb-smiles> <moldb-formula>C45H32N6O6</moldb-formula> <moldb-inchi>InChI=1S/C45H32N6O6/c52-39-37(40(53)47(32-21-9-2-10-22-32)46(39)31-19-7-1-8-20-31)45(43(56)50(35-27-15-5-16-28-35)51(44(45)57)36-29-17-6-18-30-36)38-41(54)48(33-23-11-3-12-24-33)49(42(38)55)34-25-13-4-14-26-34/h1-30,37-38H</moldb-inchi> <moldb-inchikey>NAMVGYMNDWZPDQ-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">752.2383328</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.8</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM352677</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>4,4-bis(3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)-1,2-diphenylpyrazolidine-3,5-dione</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0307034</sync-id> <structure-inchikey>NAMVGYMNDWZPDQ-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000000000000000000000000000000000000000000000000000000000000010000000000000020000000000000000004000000000000000000000000000000000000000000000000000000000000000020000000000000000004000000000000000000000000000000000000000000000000000100080000000000000000100000004008000000800108000000000000000000000100000000000000000000000000000000000000008000080000000000000000000000000000000000000000000001000000000000000000000000000000010000000000000200000000000000000040000000004040000000000001000000000020000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>7016c0508db2c670c9ee5be5a3b8aa899b1014b28197a07085bd6074ab34ea4d6c6209501384046c8502492844cd200015600b24c09f72351bee7d7d80e24016c7119c895a903c00009013c01af306000844c58171611eb753145d6244225ed7ed28652f086c3332608c8480ddd400ce788692528115c5a6f15a266502f11b07104d18194ef8a22a0c170254c82c46a8391dd81245469e8a70230ca066c0868413d7109700b2c2328a944d68077c35164ac10442a9490ac058b04ab0cce01212aa8130b4d5dbd33b1dc0a4a7571542990c412014036470738d73768c2e20034491384d3418890b28334c0405d916a08a4a50063490c2040f13199a82da0a0e46</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAA5AAAAQQAAAIABBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEHACgAAAAD AwYAKAAAAAMECAAoAAAAAwIGAGAAAAADAQYAKAAAAAMECAAoAAAAAwIHACgA AAADAwZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBgAgAAAABAYAKAAAAAMECAAoAAAAAwIHACgAAAADAwcA KAAAAAMDBgAoAAAAAwQIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAAD AwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGAGAAAAAD AQYAKAAAAAMECAAoAAAAAwIHACgAAAADAwcAKAAAAAMDBgAoAAAAAwQIACgA AAADAgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAAD AwEGQGgAAAADAwEGQGgAAAADAwELAAFoDAECaAwCA2gMAwRoDAQFaAwDBiAG ByAHCCgCBwkACQoACgsoAgoMIAwNIA0OaAwOD2gMDxBoDBARaAwREmgMCRMA ExQAFBUoAhQWIBYXABcYIBgZKAIXGiAaG2gMGxxoDBwdaAwdHmgMHh9oDBYg ICAhaAwhImgMIiNoDCMkaAwkJWgMEyYAJicAJygoAicpICkqACorICssKAIq LSAtLmgMLi9oDC8waAwwMWgMMTJoDCkzIDM0aAw0NWgMNTZoDDY3aAw3OGgM BQBoDAwGABINaAwYEwAfGmgMJSBoDCsmADItaAw4M2gMQgkAAAAGAAUEAwIB BQcGDAoJBg4PEBESDQUUExgXFgYbHB0eHxoGISIjJCUgBScmKyopBi4vMDEy LQY0NTY3ODMXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:54:35Z</structure-indexed-at> </compound>